You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九典制藥(300705.SZ):洛索洛芬鈉凝膠貼膏擬納入聯盟地區集團帶量採購範圍
格隆匯 07-21 19:24

格隆匯7月21日丨九典制藥(300705.SZ)發佈股票交易異常波動公吿稱,2021717廣東省藥品交易中心發佈了《關於徵求<阿莫西林等45藥品聯盟地區集團帶量採購文件(徵求意見稿)>意見的通知根據文件中品種範圍的要求公司產品洛索洛芬鈉凝膠貼膏擬納入聯盟地區集團帶量採購範圍。

對於公司產品洛索洛芬鈉凝膠貼膏最終是否會納入聯盟地區集團帶量採購範圍還需要等待廣東省藥品交易中心徵求意見期結束後發佈的正式文件司將及時根據後續進展履行信息披露義務

公司洛索洛芬鈉凝膠貼膏如納入聯盟地區集團帶量採購範圍,能夠加快公司產品推廣速度提高市場佔有率但由於目前尚處在徵求意見階段,該產品是否納入聯盟地區集團帶量採購範圍仍存在不確定性,公司收入和利潤的影響也存在不確定性,提醒投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account